4//SEC Filing
Schwartz Kira M. 4
Accession 0001209191-20-034219
CIK 0001714798other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 6:43 PM ET
Size
5.5 KB
Accession
0001209191-20-034219
Insider Transaction Report
Form 4
Schwartz Kira M.
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-06-02+100,000→ 100,000 totalExercise: $16.68Exp: 2030-06-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the Option shall vest on June 1, 2021; the remaining shares shall vest as to 1/36th of the shares monthly thereafter beginning on July 1, 2021, provided that the Reporting Person provides continuous service to the Issuer as of each such date.
Documents
Issuer
Prevail Therapeutics Inc.
CIK 0001714798
Entity typeother
Related Parties
1- filerCIK 0001813735
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 6:43 PM ET
- Size
- 5.5 KB